Published in Am J Clin Pathol on December 01, 1981
Epidemiological analysis of the significance of low-positive test results for antibody to hepatitis B surface and core antigens. J Clin Microbiol (1984) 1.43
Elective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus--a systematic review. Virol J (2008) 1.08
A comparative study on serologic profiles of virus hepatitis B. World J Gastroenterol (2001) 0.92
Distribution Characteristics of Hepatitis B Serological Markers in Hospitalized Children and Adolescents in Zhejiang, China between 2006 and 2010. Gut Liver (2011) 0.80
Exposure to hepatitis B: review of current concepts. Bull N Y Acad Med (1989) 0.75
A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res (1988) 77.80
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science (1989) 37.89
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science (1989) 18.79
Isolation of novel virus-like sequences associated with human hepatitis. Nat Med (1995) 4.99
Lack of protective immunity against reinfection with hepatitis C virus. Science (1992) 4.94
Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. Hepatitis Interventional Therapy Group. N Engl J Med (1989) 4.69
A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group. N Engl J Med (1990) 4.53
Inhibition of herpes simplex virus replication by phosphonoacetic acid. Antimicrob Agents Chemother (1974) 4.50
Inhibition of DNA polymerase from herpes simplex virus-infected wi-38 cells by phosphonoacetic Acid. J Virol (1975) 4.42
Prevalence of hepatitis B virus antigen as revealed by direct radioimmune assay with 125 I-antibody. J Immunol (1972) 4.25
Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br Med Bull (1990) 4.16
Suppression of herpes simplex virus infection by phosphonoacetic acid. Appl Microbiol (1973) 4.04
Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J Virol (1998) 3.73
A microtiter solid-phase radioimmunoassay for hepatitis A antigen and antibody. J Immunol (1976) 3.53
Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human non-A-E hepatitis. J Med Virol (1996) 2.98
Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med (1989) 2.77
Occupational exposure to hepatitis B virus in hospital personnel: infection or immunization? Am J Epidemiol (1982) 2.62
Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis. N Engl J Med (1982) 2.58
Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology (1983) 2.56
Comparison of two serologically distinct ribonucleic acid bacteriophages. I. Properties of the viral particles. J Bacteriol (1966) 2.52
Evaluation of methods for detection and quantitation of fetal cells and their effect on RhIgG usage. Am J Clin Pathol (1981) 2.51
Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen. J Gen Virol (1993) 2.50
Experimental infection of chimpanzees with hepatitis A virus. J Infect Dis (1975) 2.41
Genomic organization of GB viruses A and B: two new members of the Flaviviridae associated with GB agent hepatitis. J Virol (1995) 2.38
Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology (2001) 2.30
Fetomaternal hemorrhage: incidence, risk factors, time of occurrence, and clinical effects. Transfusion (1990) 2.30
Circulating immune complexes and complement activation in primary biliary cirrhosis. N Engl J Med (1978) 2.30
Genetic heterogeneity of hepatitis E virus. J Med Virol (2001) 2.29
Purification of hepatitis A antigen from feces and detection of antigen and antibody by immune adherence hemagglutination. Infect Immun (1976) 2.27
The sequence and phylogenetic analysis of a novel hepatitis E virus isolated from a patient with acute hepatitis reported in the United States. J Gen Virol (1998) 2.22
Hepatitis A virus infection: new insights from seroepidemiologic studies. J Infect Dis (1978) 2.21
Prevalence of TT virus infection in US blood donors and populations at risk for acquiring parenterally transmitted viruses. J Infect Dis (1999) 2.21
Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group. Gastroenterology (1993) 2.20
Viral hepatitis, type B. Studies on natural history and prevention re-examined. N Engl J Med (1979) 2.03
Prevention of endemic HAA-positive hepatitis with gamma globulin. Use of a simple radioimmune assay to detect HAA. N Engl J Med (1972) 2.00
The prevalence of antibody to hepatitis A antigen in various parts of the world: a pilot study. Am J Epidemiol (1977) 1.86
Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides. J Virol Methods (1992) 1.85
Performance characteristics of serologic tests for human immunodeficiency virus type 1 (HIV-1) antibody among Minnesota blood donors. Public health and clinical implications. Ann Intern Med (1989) 1.84
A hepatitis E virus variant from the United States: molecular characterization and transmission in cynomolgus macaques. J Gen Virol (1999) 1.83
Association between fulminant hepatic failure and a strain of GBV virus C. Lancet (1996) 1.82
Distribution of antibody to hepatitis a antigen in urban adult populations. N Engl J Med (1976) 1.81
Novel hepatitis E virus (HEV) isolates from Europe: evidence for additional genotypes of HEV. J Med Virol (1999) 1.77
TestPack Chlamydia, a new rapid assay for the direct detection of Chlamydia trachomatis. J Clin Microbiol (1989) 1.71
Screening donated blood and plasma for HTLV-III antibody. Facing more than one crisis? N Engl J Med (1985) 1.65
Detection of fetomaternal hemorrhage: how, when, and why. Transfusion (1991) 1.64
Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients. Blood (1990) 1.64
Etiology of sporadic hepatitis B surface antigen-negative hepatitis. Ann Intern Med (1977) 1.63
Epidemiology and clinical impact of hepatitis D virus (delta) infection. Hepatology (1985) 1.60
Serodiagnosis of viral hepatitis A by a modified competitive binding radioimmunoassay for immunoglobulin M anti-hepatitis A virus. J Clin Microbiol (1979) 1.60
A divergent genotype of hepatitis E virus in Chinese patients with acute hepatitis. J Gen Virol (1999) 1.59
Foodhandler-associated outbreak of hepatitis type A. An immune electron microscopic study. Ann Intern Med (1975) 1.58
Improved detection systems for TT virus reveal high prevalence in humans, non-human primates and farm animals. J Gen Virol (1999) 1.57
DNA probe amplification methods. J Virol Methods (1992) 1.55
Faecal shedding of hepatitis-A antigen. Lancet (1975) 1.54
Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy. Ann Intern Med (1984) 1.52
Non-A, non-B hepatitis: evolving epidemiologic and clinical perspective. Semin Liver Dis (1986) 1.51
Hepatitis A antigen particles in liver, bile, and stool of chimpanzees. J Infect Dis (1976) 1.51
Rolling circular DNA associated with Dane particles in hepatitis B virus. Nature (1975) 1.50
Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV. Hepatology (2000) 1.49
non-A, Non-B hepatitis. II. Experimental transmission, putative virus agents and markers, and prevention. Gastroenterology (1983) 1.48
Translation initiation in GB viruses A and C: evidence for internal ribosome entry and implications for genome organization. J Virol (1996) 1.46
Amplification and subtraction methods and their application to the discovery of novel human viruses. J Med Virol (1997) 1.44
Comparison of two serologically distinct ribonucleic acid bacteriophages. II. Properties of the nucleic acids and coat proteins. J Bacteriol (1966) 1.44
Identification of a novel variant of hepatitis E virus in Italy. J Med Virol (1999) 1.40
Predictors of GBV-C infection among patients referred for renal transplantation. Kidney Int (1998) 1.39
Seroepidemiological investigation of patients and family contacts in an epidemic of hepatitis A. J Med Virol (1977) 1.39
Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B. J Hepatol (2001) 1.38
Mussel-associated viral hepatitis, type A: serological confirmation. Lancet (1976) 1.36
Sequence heterogeneity within the 5'-terminal region of the hepatitis GB virus C genome and evidence for genotypes. J Hepatol (1996) 1.35
Immunoassay detection of hepatitis B surface antigen mutants. J Med Virol (1999) 1.34
Complete sequencing of a gibbon hepatitis B virus genome reveals a unique genotype distantly related to the chimpanzee hepatitis B virus. Virology (1996) 1.34
Discontinuous epitopes of hepatitis B surface antigen derived from a filamentous phage peptide library. Proc Natl Acad Sci U S A (1996) 1.32
Rapid detection of Hepatitis E virus RNA by reverse transcription-polymerase chain reaction using universal oligonucleotide primers. J Virol Methods (1999) 1.31
Prevalence studies of GB virus-C infection using reverse transcriptase-polymerase chain reaction. J Med Virol (1996) 1.31
Seroepidemiological survey of hepatitis B and C virus infections in Ghanaian children. J Med Virol (1996) 1.29
Detection of long-lasting antibody to hepatitis E virus in a US traveller to Pakistan. Lancet (1992) 1.29
Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings. Ann Intern Med (1986) 1.29
Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1993) 1.27
Hepatitis B antigen in wild-caught mosquitoes in Africa. Lancet (1972) 1.27
Halothans hepatitis: allergy or idiosyncrasy? N Engl J Med (1980) 1.26
Contrasting roles of rivers and wells as sources of drinking water on attack and fatality rates in a hepatitis E epidemic in Somalia. Am J Trop Med Hyg (1994) 1.26
False positive tests for hepatitis-associated antigen in blood donors caused by antibodies to ruminant serum proteins. J Immunol (1972) 1.26
An ELISA for detection of antibodies to the E2 protein of GB virus C. J Infect Dis (1997) 1.24
Quantitation of antibody to hepatitis A antigen by immune electron microscopy. Infect Immun (1976) 1.24
Relapsing viral hepatitis type A. J Med Virol (1985) 1.22
The high-risk liver allograft recipient. Should allocation policy consider outcome? Arch Surg (1992) 1.22
Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact Profile. Clin Ther (1994) 1.20
Identification of GB virus C variants by phylogenetic analysis of 5'-untranslated and coding region sequences. J Virol (1997) 1.19
Hepatits A virus infection in fulminant hepatitis and chronic active hepatitis. Gastroenterology (1978) 1.19
Expression of the GB virus C E2 glycoprotein using the Semliki Forest virus vector system and its utility as a serologic marker. Virology (1996) 1.18
Alterations of T-cell subsets in primary biliary cirrhosis. Clin Exp Immunol (1982) 1.16
Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine. J Infect Dis (1999) 1.16
Detection of cytomegalovirus antibody by immune adherence hemagglutination. Proc Soc Exp Biol Med (1976) 1.15
Enhanced in vitro cell-mediated cytotoxicity in chronic hepatitis B virus infection: absence of specificity for virus-expressed antigen on target cell membranes. J Immunol (1980) 1.14
Use of IgM-hepatitis A antibody testing. Investigating a common-source, food borne outbreak. JAMA (1981) 1.13